Cardiovascular disease and type 2 diabetes mellitus: A multifaceted symbiosis

References

• Fox C. S., Sullivan L., D'Agostino R. B Sr., Wilson P. W. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care 2004; 27: 704–8
   PubMed Web of Science ®Google Scholar
• Juutilainen A., Lehto S., Ronnemaa T., Pyorala K., Laakso M. T2DM as a ‘coronary heart disease equivalent’: An 18‐year prospective population‐based study in Finnish subjects. Diabetes Care 2005; 28: 2901–7
   PubMed Web of Science ®Google Scholar
• Juutilainen A., Kortelainen S., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Gender difference in the impact of T2DM on coronary heart disease risk. Diabetes Care 2004; 27: 2898–904
   PubMed Web of Science ®Google Scholar
• NIDDK. Diabetes Statistics. NIH Publication No. 06‐3892. Available at: http://diabetes.niddk.nih.gov (accessed March 2007)
   Google Scholar
• McGuire D. K., Emanuelsson H., Granger C. B., Magnus Ohman E., Moliterno D. J., White H. D., et al. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO‐IIb study. GUSTO IIb Investigators. Eur Heart J 2000; 21: 1750–8
   PubMed Web of Science ®Google Scholar
• Natali A., Vichi S., Landi P., Severi S., L'Abbate A., Ferrannini E. Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia 2000; 43: 632–41
   PubMedGoogle Scholar
• Norhammar A., Malmberg K., Diderholm E., Lagerqvist B., Lindahl B., Ryden L., et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 2004; 43: 585–91
   PubMed Web of Science ®Google Scholar
• Dolan N. C., Liu K., Criqui M. H., Greenland P., Guralnik J. M., Chan C., et al. Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 2002; 25: 113–20
   PubMed Web of Science ®Google Scholar
• Kiers L., Davis S. M., Larkins R., Hopper J., Tress B., Rossiter S. C., et al. Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry 1992; 55: 263–70
   PubMedGoogle Scholar
• Williams R., Van Gaal L., Lucioni C., CODE‐2 Advisory Board. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 2002; 45: S13–17
   PubMed Web of Science ®Google Scholar
• Johansen O. E., Birkeland K. I., Orvik E., Flesland Ø., Wergeland R., Ueland T., et al. Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects. Scand J Clin Lab Invest 2007; 67: 306–16
   PubMed Web of Science ®Google Scholar
• Lanzer P. Vascular multimorbidity in patients with a documented coronary artery disease. Z Kardiol 2003; 92: 650–9
   PubMedGoogle Scholar
• Ledru F., Ducimetiere P., Battaglia S., Courbon D., Beverelli F., Guize L., et al. New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. J Am Coll Cardiol 2001; 37: 1543–50
   PubMed Web of Science ®Google Scholar
• Criqui M. H., Denenberg J. O., Langer R. D., Fronek A. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997; 2: 221–6
   PubMedGoogle Scholar
• Muller W. A. Diabetes mellitus – long time survival. J Insur Med 1998; 30: 17–27
   PubMedGoogle Scholar
• Tunstall‐Pedoe H., Kuulasmaa K., Mahonen M., Tolonen H., Ruokokoski E., Amouyel P. Contribution of trends in survival and coronary‐event rates to changes in coronary heart disease mortality: 10‐year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 1999; 353: 1547–57
   PubMed Web of Science ®Google Scholar
• Gu K., Cowie C. C., Harris M. I. Diabetes and decline in heart disease mortality in US adults. J Am Med Assoc 1999; 281: 1291–7
   PubMed Web of Science ®Google Scholar
• Fergus T. S., Fazel R., Fang J., Chetcuti S., Smith D. E., Kline‐Rogers E., et al. Presentation, management, and outcomes of diabetic patients compared to non‐diabetic patients admitted for acute coronary syndromes. Heart 2004; 90: 1051–2
   PubMedGoogle Scholar
• World Health Organisation (2006). Available at: http://www.who.int/diabetes/facts/world_figures/en/ (accessed March 2007)
   Google Scholar
• American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2005; 28: S37–42
   PubMed Web of Science ®Google Scholar
• World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. 2006, World Health Organization, Geneva; 2006
   Google Scholar
• Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–53
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation (2006). Diabetes Atlas, 3rd edn. Available at: http://www eatlas idf org/media/ 2006 (accessed March 2007)
   Google Scholar
• Ko G. T., Chan J. C., Woo J., Cockram C. S. Use of the 1997 American Diabetes Association diagnostic criteria for diabetes in a Hong Kong Chinese population. Diabetes Care 1998; 21: 2094–7
   PubMedGoogle Scholar
• Larsson H., Berglund G., Lindgarde F., Ahren B. Comparison of ADA and WHO criteria for diagnosis of diabetes and glucose intolerance. Diabetologia 1998; 41: 1124–5
   PubMedGoogle Scholar
• Johansen O. E., Birkeland K. I., Brustad E., Aaser E., Lindahl A. K., Midha R., et al. Undiagnosed dysglycaemia and inflammation in cardiovascular disease. Eur J Clin Invest 2006; 36: 544–51
   PubMed Web of Science ®Google Scholar
• Qiao Q., Lindstrom J., Valle T. T., Tuomilehto J. Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia. Diabetes Med 2003; 20: 1027–33
   PubMed Web of Science ®Google Scholar
• Norhammar A., Tenerz A., Nilsson G., Hamsten A., Efendic S., Ryden L., et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140–4
   PubMed Web of Science ®Google Scholar
• Dowse G. K., Zimmet P., Gareeboo H., George K., Alberti KG., Tuomilehto J., et al. 1991; 14: 271–82, Abdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care 1991
   Google Scholar
• Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Targher G., et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47: 1643–9
   PubMed Web of Science ®Google Scholar
• Chan S. P., Gelding S. V., McManus R. J., Nicholls J. S., Anyaoku V., Niththyananthan R., et al. Abnormalities of intermediary metabolism following a gestational diabetic pregnancy. Clin Endocrinol 1992; 36: 417–20
   PubMedGoogle Scholar
• Hagen M., Hjelmesaeth J., Jenssen T., Morkrid L., Hartmann A. A 6‐year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients. Nephrol Dial Transpl 2003; 18: 2154–9
   PubMed Web of Science ®Google Scholar
• DECODE Study Group. Age‐ and sex‐specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003; 26: 61–9
   PubMed Web of Science ®Google Scholar
• Ramachandran A., Snehalatha C., Dharmaraj D., Viswanathan M. Prevalence of glucose intolerance in Asian Indians. Urban–rural difference and significance of upper body adiposity. Diabetes Care 1992; 15: 1348–55
   PubMed Web of Science ®Google Scholar
• Kriketos A. D., Greenfield J. R., Peake P. W., Furler S. M., Denyer G. S., Charlesworth J. A., et al. Inflammation, insulin resistance, and adiposity: a study of first‐degree relatives of type 2 diabetic subjects. Diabetes Care 2004; 27: 2033–40
   PubMedGoogle Scholar
• Khan A., Lasker S. S., Chowdhury T. A. Are spouses of patients with T2DM at increased risk of developing diabetes?. Diabetes Care 2003; 26: 710–12
   PubMedGoogle Scholar
• Singleton J. R., Smith A. G., Russell J. W., Feldman E. L. Microvascular complications of impaired glucose tolerance. Diabetes 2003; 52: 2867–73
   PubMed Web of Science ®Google Scholar
• Coutinho M., Gerstein H. C., Wang Y., Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233–40
   PubMed Web of Science ®Google Scholar
• Dekker J. M., Balkau B. Counterpoint: impaired fasting glucose – the case against the new American Diabetes Association guidelines. Diabetes Care 2006; 29: 1173–5
   PubMed Web of Science ®Google Scholar
• World Health Organization, Department of Noncommunicable Disease Management. Screening for T2DM; Report of a World Health Organization and International Diabetes Federation meeting. World Health Organization, Geneva. Available at www.who.org
   Google Scholar
• Kukreja N., Wilkinson J. R., MacDuff A., Galloway C. F., Fox K. M. Under‐diagnosis of diabetes mellitus in patients with coronary artery disease. Int J Cardiol 2004; 97: 77–82
   PubMedGoogle Scholar
• Chiasson J. L., Josse R. G., Gomis R., Hanefeld M., Karasik A., Laakso M., STOP‐NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP‐NIDDM trial. J Am Med Assoc 2003; 290: 486–94
   PubMed Web of Science ®Google Scholar
• Tuomilehto J., Lindstrom J. The major diabetes prevention trials. Curr Diabetes Rept 2003; 3: 115–22
   PubMedGoogle Scholar
• DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006; 368: 1096–105
   PubMed Web of Science ®Google Scholar
• Lindstrom J., Tuomilehto J. The Diabetes Risk Score: A practical tool to predict T2DM risk. Diabetes Care 2003; 26: 725–31
   PubMed Web of Science ®Google Scholar
• Groop L., Tuomi T., Rowley M., Zimmet P., Mackay I. R. Latent autoimmune diabetes in adults (LADA) – More than a name. Diabetologia 2006; 49: 1996–8
   PubMedGoogle Scholar
• Fajans S. S., Bell G. I., Polonsky K. S. Molecular mechanisms and clinical pathophysiology of maturity‐onset diabetes of the young. N Engl J Med 2001; 345: 971–80
   PubMed Web of Science ®Google Scholar
• Borg H., Gottsater A., Fernlund P., Sundkvist G. A 12‐year prospective study of the relationship between islet antibodies and beta‐cell function at and after the diagnosis in patients with adult‐onset diabetes. Diabetes 2002; 51: 1754–62
   PubMedGoogle Scholar
• U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 1995; 44: 1249–58
   PubMed Web of Science ®Google Scholar
• Turner R. C., Millns H., Neil H. A., Stratton I. M., Manley S. E., Matthews D. R., et al. Risk factors for coronary artery disease in non‐insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). Br Med J 1998; 316: 823–8
   PubMed Web of Science ®Google Scholar
• Johansen O. E., Birkeland K. I. Preventing macrovascular disease in patients with T2DM mellitus. Am J Cardiovasc Drugs 2003; 3: 283–97
   PubMedGoogle Scholar
• Ceriello A., Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24: 816–23
   PubMed Web of Science ®Google Scholar
• Pickup J. C., Mattock M. B., Chusney G. D., Burt D. NIDDM as a disease of the innate immune system: association of acute‐phase reactants and interleukin‐6 with metabolic syndrome X. Diabetologia 1997; 40: 1286–92
   PubMed Web of Science ®Google Scholar
• Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002; 106: 2067–72
   PubMed Web of Science ®Google Scholar
• Rifai N., Ridker P. M. Inflammatory markers and coronary heart disease. Curr Opin Lipidol 2002; 13: 383–9
   PubMed Web of Science ®Google Scholar
• Janssen J. A., Lamberts S. W. The role of IGF‐I in the development of cardiovascular disease in T2DM mellitus: is prevention possible?. Eur J Endocrinol 2002; 146: 467–77
   PubMed Web of Science ®Google Scholar
• Roestenberg P., van Nieuwenhoven F. A., Wieten L., Boer P., Diekman T., Tiller A. M., et al. Connective tissue growth factor is increased in plasma of type 1 diabetic patients with nephropathy. Diabetes Care 2004; 27: 1164–70
   PubMed Web of Science ®Google Scholar
• Vinik A. I., Maser R. E., Mitchell B. D., Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553–79
   PubMed Web of Science ®Google Scholar
• Janand‐Delenne B., Savin B., Habib G., Bory M., Vague P., Lassmann‐Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 1999; 22: 1396–400
   PubMed Web of Science ®Google Scholar
• Marwick T. H., Case C., Sawada S., Vasey C., Short L., Lauer M. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care 2002; 25: 1042–8
   PubMed Web of Science ®Google Scholar
• Johansen O. E., Bjurø T., Endresen K., Blaasaas K. G., Birkeland K. I., Aakhus S., et al. Heart rate adjustments and analysis of recovery patterns of ST‐segment depression in type 2 diabetes. Int J Cardiol 2007, In press. (DOI: 10.1016/j.ijcard.2007.04.022)
   Google Scholar
• Grossman E., Messerli F. H. Diabetic and hypertensive heart disease. Ann Intern Med 1996; 125: 304–10
   PubMed Web of Science ®Google Scholar
• Waller B. F., Palumbo P. J., Lie J. T., Roberts W. C. Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med 1980; 69: 498–506
   PubMed Web of Science ®Google Scholar
• Vlietstra R. E., Kronmal R. A., Frye R. L., Seth A. K., Tristani F. E., Killip T III. Factors affecting the extent and severity of coronary artery disease in patients enrolled in the coronary artery surgery study. Arteriosclerosis 1982; 2: 208–15
   PubMedGoogle Scholar
• Pajunen P., Nieminen M. S., Taskinen M. R., Syvanne M. Quantitative comparison of angiographic characteristics of coronary artery disease in patients with noninsulin‐dependent diabetes mellitus compared with matched nondiabetic control subjects. Am J Cardiol 1997; 80: 550–6
   PubMed Web of Science ®Google Scholar
• Heller G. V. Evaluation of the patient with diabetes mellitus and suspected coronary artery disease. Am J Med 2005; 118 Suppl 2: 9S–14
   Google Scholar
• Enbergs A., Burger R., Reinecke H., Borggrefe M., Breithardt G., Kerber S. Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. Eur Heart J 2000; 21: 45–52
   PubMed Web of Science ®Google Scholar
• Thurnheer R., Muntwyler J., Stammberger U., Bloch K. E., Zollinger A., Weder W., et al. Coronary artery disease in patients undergoing lung volume reduction surgery for emphysema. Chest 1997; 112: 122–8
   PubMed Web of Science ®Google Scholar
• Leung D. Y., Dawson I. G., Thomas J. D., Marwick T. H. Accuracy and cost‐effectiveness of exercise echocardiography for detection of coronary artery disease in patients with mitral valve prolapse. Am Heart J 1997; 134: 1052–7
   PubMedGoogle Scholar
• Gandelman G., Bodenheimer M. M. Screening coronary arteriography in the primary prevention of coronary artery disease. Heart Dis 2003; 5: 335–44
   PubMedGoogle Scholar
• Mintz G. S., Painter J. A., Pichard A. D., Kent K. M., Satler L. F., Popma J. J., et al. Atherosclerosis in angiographically “normal” coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995; 25: 1479–85
   PubMed Web of Science ®Google Scholar
• Fitzgerald P. J. Ruptured plaque. Catheter Cardiovasc Interv 2004; 63: 317–18
   PubMedGoogle Scholar
• Schindler T. H., Nitzsche E., Magosaki N., Brink I., Mix M., Olschewski M., et al. Regional myocardial perfusion defects during exercise, as assessed by three dimensional integration of morphology and function, in relation to abnormal endothelium dependent vasoreactivity of the coronary microcirculation. Heart 2003; 89: 517–26
   PubMedGoogle Scholar
• Williams S. B., Goldfine A. B., Timimi F. K., Ting H. H., Roddy M. A., Simonson D. C., et al. Acute hyperglycemia attenuates endothelium‐dependent vasodilation in humans in vivo. Circulation 1998; 97: 1695–701
   PubMed Web of Science ®Google Scholar
• Blumenthal H. T., Alex M., Goldenberg S. A study of lesions of the intramural coronary artery branches in diabetes mellitus. Arch Pathol 1960; 70: 27–42
   Google Scholar
• Kersten J. R., Toller W. G., Tessmer J. P., Pagel P. S., Warltier D. C. Hyperglycemia reduces coronary collateral blood flow through a nitric oxide‐mediated mechanism. Am J Physiol Heart Circ Physiol 2001; 281: H2097–104
   Web of Science ®Google Scholar
• Gould K. L. Physiological severity of coronary artery stenosis. Am J Physiol Heart Circ Physiol 2006; 291: H2583–5
   Google Scholar
• Panichi V., Maggiore U., Taccola D., Migliori M., Rizza G. M., Consani C., et al. Interleukin‐6 is a stronger predictor of total and cardiovascular mortality than C‐reactive protein in haemodialysis patients. Nephrol Dial Transpl 2004; 19: 1154–60
   PubMed Web of Science ®Google Scholar
• Faglia E., Manuela M., Antonella Q., Michela G., Vincenzo C., Maurizio C., et al. Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with T2DM mellitus at high cardiovascular risk: an open‐label randomized pilot study. Am Heart J 2005; 149: e1–6
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10–11 February 1998, Miami, Florida. Diabetes Care 1998; 21: 1551–9
   PubMedGoogle Scholar
• Cramer J. A. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27: 1218–24
   PubMed Web of Science ®Google Scholar
• Evans J. M., Ogston S. A., Emslie‐Smith A., Morris A. D. Risk of mortality and adverse cardiovascular outcomes in T2DM: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 2006; 49: 930–6
   PubMed Web of Science ®Google Scholar
• Dormandy J. A., Charbonnel B., Eckland D. J., Erdmann E., Massi‐Benedetti M., Moules I. K., et al. Secondary prevention of macrovascular events in patients with T2DM in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 2005; 366: 1279–89
   PubMed Web of Science ®Google Scholar
• Krein S. L., Vijan S., Pogach L. M., Hogan M. M., Kerr E. A. Aspirin use and counseling about aspirin among patients with diabetes. Diabetes Care 2002; 25: 965–70
   PubMedGoogle Scholar
• Norhammar A., Malmberg K., Ryden L., Tornvall P., Stenestrand U., Wallentin L. Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS‐HIA. Under utilisation of evidence‐based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003; 24: 838–44
   PubMed Web of Science ®Google Scholar
• Brogan G. X Jr., Peterson E. D., Mulgund J., Bhatt D. L., Ohman E. M., Gibler W. B., et al. Treatment disparities in the care of patients with and without diabetes presenting with non‐ST‐segment elevation acute coronary syndromes. Diabetes Care 2006; 29: 9–14
   PubMedGoogle Scholar
• Kersten J. R., Schmeling T. J., Orth K. G., Pagel P. S., Warltier D. C. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol 1998; 275: H721–5
   Google Scholar
• Oliver M. F., Opie L. H. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994; 343: 155–8
   PubMed Web of Science ®Google Scholar
• Zabalgoitia M., Ismaeil M. F., Anderson L., Maklady F. A. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well controlled T2DM mellitus. Am J Cardiol 2001; 87: 320–3
   PubMed Web of Science ®Google Scholar
• Gresele P., Guglielmini G., De Angelis M., Ciferri S., Ciofetta M., Falcinelli E., et al. Acute, short‐term hyperglycemia enhances shear stress‐induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 2003; 41: 1013–20
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of Medical Care in Diabetes – 2006. Diabetes Care 2006; 29: S4–42
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation. The IDF Global Guideline for T2DM. Available at: http://www.idf.org (accessed March 2007)
   Google Scholar
• Gaede P., Vedel P., Larsen N., Jensen G. V., Parving H. H., Pedersen O. Multifactorial intervention and cardiovascular disease in patients with T2DM. N Engl J Med 2003; 348: 383–93
   PubMed Web of Science ®Google Scholar
• Menard J., Payette H., Baillargeon J. P., Maheux P., Lepage S., Tessier D., et al. Efficacy of intensive multitherapy for patients with T2DM mellitus: a randomized controlled trial. CMAJ 2005; 173: 1457–66
   PubMed Web of Science ®Google Scholar
• Kennedy A. G., MacLean C. D., Littenberg B., Ades P. A., Pinckney R. G. The challenge of achieving national cholesterol goals in patients with diabetes. Diabetes Care 2005; 28: 1029–34
   PubMed Web of Science ®Google Scholar
• Saydah S. H., Fradkin J., Cowie C. C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J Am Med Assoc 2004; 291: 335–42
   PubMed Web of Science ®Google Scholar
• Resnick H. E., Foster G. L., Bardsley J., Ratner R. E. Achievement of American Diabetes Association Clinical Practice Recommendations Among U.S. Adults With Diabetes, 1999–2002: The National Health and Nutrition Examination Survey. Diabetes Care 2006; 29: 531–7
   PubMed Web of Science ®Google Scholar
• Liebl A., Mata M., Eschwege E., ODE‐2 Advisory Board. Evaluation of risk factors for development of complications in Type II diabetes in Europe. Diabetologia 2002; 45: S23–8
   PubMed Web of Science ®Google Scholar
• Johansen O. E., Gullestad L., Blaasaas K. G., Orvik E., Birkeland K. I. Effects of structured hospital based‐care vs. standard care for type 2 diabetes – The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial. Diabetes Med 2007, In press. (DOI: 10.1111/j.1464‐5491.2007.02198.x)
   PubMedGoogle Scholar
• Renders C. M., Valk G. D., Griffin S., Wagner E. H., Eijk J. T., Assendelft W. J. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database Syst Rev 2001; 1: CD001481
   PubMedGoogle Scholar
• Shojania K. G., Ranji S. R., McDonald K. M., Grimshaw J. M., Sundaram V., Rushakoff R. J., et al. Effects of quality improvement strategies for T2DM on glycemic control: a meta‐regression analysis. J Am Med Assoc 2006; 296: 427–40
   PubMed Web of Science ®Google Scholar
• Griffin S., Kinmont A. L. Systems for routine surveillance for people with diabetes. Cochrane Database Syst Rev 1998; 1: CD000541
   Google Scholar
• Olivarius N. F., Beck‐Nielsen H., Andreasen A. H., Horder M., Pedersen P. A. Randomised controlled trial of structured personal care of T2DM mellitus. Br Med J 2001; 323: 970–5
   PubMed Web of Science ®Google Scholar
• Phillips L. S., Ziemer D. C., Doyle J. P., Barnes C. S., Kolm P., Branch W. T., et al. An endocrinologist‐supported intervention aimed at providers improves diabetes management in a primary care site: improving primary care of African Americans with diabetes (IPCAAD) 7. Diabetes Care 2005; 28: 2352–60
   PubMedGoogle Scholar
• Hall L. M., Jung R. T., Leese G. P. Controlled trial of effect of documented cardiovascular risk scores on prescribing. Br Med J 2003; 326: 251–2
   PubMed Web of Science ®Google Scholar
• McMahon G. T., Gomes H. E., Hickson Hohne S., Hu T. M., Levine B. A., Conlin P. R. Web‐based care management in patients with poorly controlled diabetes. Diabetes Care 2005; 28: 1624–9
   PubMed Web of Science ®Google Scholar
• Orvik E., Johansen O. E., Gullestad L., Birkeland K. I. Health‐related quality of life in type 2 diabetic patients compared to their spouses: sub‐study of the Asker and Baerum Cardiovascular Diabetes Study. Eur Diabetes Nursing 2006; 3: 21–6
   Google Scholar
• Steinbrook R. Facing the diabetes epidemic – mandatory reporting of glycosylated hemoglobin values in New York City. N Engl J Med 2006; 354: 545–8
   PubMed Web of Science ®Google Scholar